MedTrace Logo

Safety Study of Carotid Body Neurostimulation to Treat Cerebral Vasospasm

NCT02129413 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2015-02-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and performance of the Delta system in the treatment of cerebral vasospasm post aneurysmal subarachnoid hemorrhage (aSAH) patients.

Conditions

  • Aneurysmal Subarachnoid Hemorrhage
  • Cerebral Vasospasm

Interventions

DEVICE

Delta system

Sponsors & Collaborators

  • Samson NeuroSciences

    lead INDUSTRY

Principal Investigators

  • Peter Vajkoczy, Prof. · Charite - Universitätsmedizin, Department of Neurosurgery (Campus Virchow Klinikum), Berlin 113353, Germany

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-08-31

Countries

  • Czechia
  • Germany
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02129413 on ClinicalTrials.gov